First humans test new metabolic drug
NCT ID NCT07417124
Summary
This is the first study in humans to check if a new drug called SNS851 is safe and how it moves through the body. It will involve 52 healthy adults who will receive injections under the skin. The main goal is to see what side effects occur and how well people tolerate the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Veritus Research
RECRUITINGMelbourne, Australia
Conditions
Explore the condition pages connected to this study.